Actraphane HM New Zealand - English - Medsafe (Medicines Safety Authority)

actraphane hm

novo nordisk pharmaceuticals ltd - insulin, human, recombinant dna origin 70 iu/ml; isophane insulin, human 30 iu/ml - solution for injection - active: insulin, human, recombinant dna origin 70 iu/ml isophane insulin, human 30 iu/ml

Humulin 30/70 New Zealand - English - Medsafe (Medicines Safety Authority)

humulin 30/70

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Humulin NPH New Zealand - English - Medsafe (Medicines Safety Authority)

humulin nph

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus

Humulin R New Zealand - English - Medsafe (Medicines Safety Authority)

humulin r

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: glycerol hydrochloric acid as 10% solution for ph adjustment metacresol sodium hydroxide as 10% solution for ph adjustment water for injection - humulin is indicated for the treatment of insulin-requiring diabetes mellitus.

Hypurin Neutral Insulin New Zealand - English - Medsafe (Medicines Safety Authority)

hypurin neutral insulin

healthcare distributors ltd - insulin, human, recombinant dna origin 100 iu/ml - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 iu/ml

Mixtard 50/50 (Human) New Zealand - English - Medsafe (Medicines Safety Authority)

mixtard 50/50 (human)

novo nordisk pharmaceuticals ltd - insulin, human, recombinant dna origin 50 iu/ml; isophane insulin, human 50 iu/ml - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 50 iu/ml isophane insulin, human 50 iu/ml

Velosulin (Human) New Zealand - English - Medsafe (Medicines Safety Authority)

velosulin (human)

novo nordisk pharmaceuticals ltd - insulin, human, recombinant dna origin 100 iu/ml - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 iu/ml

Insulin Human Winthrop European Union - English - EMA (European Medicines Agency)

insulin human winthrop

sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.

Kirsty Insulin Aspart Injection (rDNA Origin) 100UmL Pre-filled Pen Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

kirsty insulin aspart injection (rdna origin) 100uml pre-filled pen

biocon sdn bhd - insulin aspart -

Humulin 80/20 New Zealand - English - Medsafe (Medicines Safety Authority)

humulin 80/20

eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 80% isophane and 20% regular insulin) - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 80% isophane and 20% regular insulin) excipient: dibasic sodium phosphate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection